Kick-Start Your Oncology and Hereditary Cancer Testing Program: Velsera’s Ready Solutions for Diverse Clinical Genomic Assays
Wednesday, November 15, 2023
11:00 AM – 11:50 AM MST
Powerful assay options are available for multiple cancer and inherited disease indications, but few offer out-of-the-box workflow management or clinical reporting solutions. Velsera solves this problem by integrating the best assays on the market with its suite of NGS wet lab orchestration tools, quality and evidence review interface, and interpretation and reporting automation. In this session, we describe Velsera’s robust, turnkey offerings for rapid implementation of your assay of choice, highlighting our customers’ experiences launching their clinical tests.